Riskpilot← Back to searchSign inGet full accessPHARMAS AS
ASActiveOrg 898309282Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20120 employees
Revenue 2021
NOK 0
EBITDA margin
—
+68% vs 2020
Equity ratio
100.0%
Financial strength
Net profit 2021
NOK -14K
-281% vs 2020
| Revenue | NOK 0 | — |
| EBITDA | NOK -1K | +68% |
| Net profit | NOK -14K | -281% |
| Total assets | NOK 46K | -23% |
| Equity | NOK 46K | -23% |
| Employees | 0 | — |
Legal name
PHARMAS AS
Org number
898309282
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. mai 2012
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Selskapets formål er å drive varehandel kjøp, produksjon, salg, distribusjon og rådgivning innen legemidler og annet som naturlig står i den forbindelse, samt eie, drift eller deltagelse i andre selskaper.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −7 | −7 | −2 | −4 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −7 | −7 | −2 | −4 | −1 |
| Net financials | 0 | 0 | 0 | 0 | −12 |
| Profit before tax | −7 | −7 | −2 | −4 | −14 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −7 | −7 | −2 | −4 | −14 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 72 | 65 | 88 | 60 | 46 |
| Equity | 72 | 65 | 63 | 60 | 46 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 25 | 0 | 0 |
| Total debt | 0 | 0 | 25 | 0 | 0 |
EBITDA margin
-114000.0%
This company
15.8%
Market median
-721619% vs market
20172021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20172021
Return on equity
-29.6%
This company
18.4%
Market median
-261% vs market
20172021
Net profit margin
-1364000.0%
This company
8.1%
Market median
-16839606% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2012 | |
| Deputy Chairman | 2012 | |
| Board of Directors | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PHARMAS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Kristiansen | Chairman | 0 companies |
| Sissel Margaret Svartnes | Deputy Chairman | 0 companies |
| Harald Foss | Board of Directors | 0 companies |